Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA's e-adverse event system will eventually apply to devices

This article was originally published in The Silver Sheet

Executive Summary

FDA's electronic "rational questionnaire" adverse event data collection system will initially only accept reportable food events, and then expand to veterinary drug events, followed by reports for devices, drugs and other products regulated by the agency, according to a May 20 Federal Register notice. All sections of FDA should be using the system by 2011, the agency says in the notice. The goal of the questionnaire is to offer a user-friendly, guided approach to anyone submitting an adverse event report to FDA's MedWatch Plus electronic portal, which still is in development. Mandatory event reporters, such as device companies, will continue to have the option of relying on the current electronic gateway-to-gateway data collection system ("The Silver Sheet" November 2008)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036364

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel